TP53 and neoplasm: A more recent study of Mga function in cancer that expanded upon the above results indicated that CRISPR-mediated Mga inactivation accelerated tumor growth and shortened survival in both the KrasLSL-G12D and KrasLSL-G12D+Tp53−/− models of lung cancer [29,30].